Shilpa Medicare Limited

NSEI:SHILPAMED 주식 보고서

시가총액: ₹77.5b

Shilpa Medicare 관리

관리 기준 확인 4/4

Shilpa Medicare CEO는 Vishnukanth Bhutada, Aug2022 에 임명되었습니다 의 임기는 2.25 년입니다. 총 연간 보상은 ₹ 35.00M, 100% 로 구성됩니다. 100% 급여 및 0% 보너스(회사 주식 및 옵션 포함). 는 ₹ 6.88B 가치에 해당하는 회사 주식의 8.87% 직접 소유합니다. 6.88B. 경영진과 이사회의 평균 재임 기간은 각각 2.5 년과 3.2 년입니다.

주요 정보

Vishnukanth Bhutada

최고 경영자

₹35.0m

총 보상

CEO 급여 비율100.0%
CEO 임기2.3yrs
CEO 소유권8.9%
경영진 평균 재임 기간2.5yrs
이사회 평균 재임 기간3.2yrs

최근 관리 업데이트

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Recent updates

What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Sep 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

Jul 05
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Apr 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Feb 21
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

Jan 02
Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Mar 17
Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Sep 07
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Aug 14
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Jan 27
Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Sep 21
Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jun 17
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 07
Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Feb 20
Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jan 26
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

CEO 보상 분석

Vishnukanth Bhutada 의 보수는 Shilpa Medicare 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

₹611m

Jun 30 2024n/an/a

₹448m

Mar 31 2024₹35m₹35m

₹319m

Dec 31 2023n/an/a

-₹7m

Sep 30 2023n/an/a

-₹119m

Jun 30 2023n/an/a

-₹321m

Mar 31 2023₹35m₹35m

-₹325m

Dec 31 2022n/an/a

₹51m

Sep 30 2022n/an/a

₹213m

Jun 30 2022n/an/a

₹599m

Mar 31 2022₹97m₹16m

₹607m

Dec 31 2021n/an/a

₹395m

Sep 30 2021n/an/a

₹376m

Jun 30 2021n/an/a

₹631m

Mar 31 2021₹97m₹16m

₹1b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹99m₹10m

₹2b

Dec 31 2019n/an/a

₹1b

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹944m

Mar 31 2019₹75m₹10m

₹1b

Dec 31 2018n/an/a

₹1b

Sep 30 2018n/an/a

₹1b

Jun 30 2018n/an/a

₹1b

Mar 31 2018₹81m₹16m

₹1b

보상 대 시장: Vishnukanth 의 총 보상 ($USD 414.61K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 355.62K ).

보상과 수익: Vishnukanth 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Vishnukanth Bhutada (62 yo)

2.3yrs

테뉴어

₹35,000,000

보상

Mr. Vishnukanth Chaturbhuj Bhutada, B. Pharm. serves as the Managing Director of Shilpa Medicare Limited since August 11, 2022 . Mr. Bhutada joined Shilpa Medicare Limited in November 1987.He serves as th...

리더십 팀

이름위치테뉴어보상소유권
Vishnukanth Bhutada
MD & Director2.3yrs₹35.00m8.87%
₹ 6.9b
Alpesh Dalal
Chief Financial Officer3.5yrs₹14.73m0.0023%
₹ 1.8m
Sharath Kalakota
VP of Projects & Operations and Whole-Time Directorno data₹16.26m0.032%
₹ 25.1m
Ritu Tiwary
Company Secretary & Compliance Officer2.5yrs₹4.51m데이터 없음
Jayant Karajgi
Chief Operating Officer of Formulationsno data₹26.95m데이터 없음
Ganeshchandra Sonavane
President of Global R&Dno data₹11.50m데이터 없음
Rajeev Saxena
Senior Vice President – Domestic Formulations and Biologicsno data₹3.90m데이터 없음
Abhay Sapre
Senior Vice President of Formulationno data₹12.50m데이터 없음
Smita Holey
Executive Vice President – Formulations for Small Moleculesno data₹2.50m데이터 없음
Awez Pathan
Vice Presidentno data₹12.77m데이터 없음
Pramod Kumar
Senior Vice President of Technicalno data₹6.06m데이터 없음
P. V. Rao
Chief Human Resource Officerno data데이터 없음데이터 없음

2.5yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 관리: SHILPAMED 의 관리팀은 경험 ( 2.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Vishnukanth Bhutada
MD & Director37yrs₹35.00m8.87%
₹ 6.9b
Sharath Kalakota
VP of Projects & Operations and Whole-Time Director5.1yrs₹16.26m0.032%
₹ 25.1m
Arvind Vasudeva
Non-Executive Independent Director3.2yrs₹3.00m데이터 없음
Kamal Sharma
Non-Executive Independent Director2.3yrs₹3.00m데이터 없음
Hetal Gandhi
Non-Executive Independent Director3.2yrs₹4.00m0.0092%
₹ 7.1m
Om Inani
Non-Executive Chairman36.7yrs₹350.00k3.3%
₹ 2.6b
Anita Bandyopadhyay
Independent Women Director2.3yrs₹1.80m데이터 없음

3.2yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: SHILPAMED 의 이사회는 경험(평균 재직 기간 3.2 년)으로 간주됩니다.